The use of real-world evidence can prevent pharma companies from performing studies based on flawed data.
Dr. Samy Suissa and Dr. Meg Richards
Advertisement
Articles by Dr. Samy Suissa and Dr. Meg Richards
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Ultragenyx Shares Drop Following Failed Phase III Clinical Trial
2
Novartis, Bristol Myers Pause Autoimmune CAR-T Trials Over Safety Concerns: Report
3
What Moments in FDA’s Review Process Should Patients and Providers be Watching Closely?
4
How New Therapies are Tackling Unmet Needs in IBS
5